Predictors of "brain fog" 1 year after COVID-19 disease.


Journal

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175

Informations de publication

Date de publication:
Oct 2022
Historique:
received: 07 06 2022
accepted: 18 07 2022
pubmed: 6 8 2022
medline: 17 9 2022
entrez: 5 8 2022
Statut: ppublish

Résumé

Brain fog has been described up to 1 year after SARS-CoV-2 infection, notwithstanding the underlying mechanisms are still poorly investigated. In this study, we aimed to evaluate the prevalence of cognitive complaints at 1-year follow-up and to identify the factors related to persistent brain fog in COVID-19 patients. Out of 246 COVID patients, hospitalized from March 1st to May 31st, a sample of 137 patients accepted to be evaluated at 1 year from discharge, through a full clinical, neurological, and psychological examination, including the Montreal Cognitive Assessment (MoCA), impact of event scale-revised (IES-R), Zung self-rating depression scale (SDS), Zung self-rating anxiety scale (SAS), and fatigue severity scale (FSS). Subjects with prior cognitive impairment and/or psychiatric disorders were excluded. Patients with cognitive disorders exhibited lower MoCA score (22.9 ± 4.3 vs. 26.3 ± 3.1, p = 0.002) and higher IES-R score (33.7 ± 18.5 vs. 26.4 ± 16.3, p = 0.050), SDS score (40.9 ± 6.5 vs. 35.5 ± 8.6, p = 0.004), and fatigue severity scale score (33.6 ± 16.1 vs. 23.7 ± 12.5, p = 0.001), compared to patients without cognitive complaints. Logistic regression showed a significant correlation between brain fog and the self-rating depression scale values (p = 0.020), adjusted for age (p = 0.445), sex (p = 0.178), premorbid Cumulative Illness Rating Scale (CIRS) (p = 0.288), COVID-19 severity (BCRSS) (p = 0.964), education level (p = 0.784) and MoCA score (p = 0.909). Our study showed depression as the strongest predictor of persistent brain fog, adjusting for demographic and clinical variables. Wider longitudinal studies are warranted to better explain cognitive difficulties after COVID-19.

Identifiants

pubmed: 35930181
doi: 10.1007/s10072-022-06285-4
pii: 10.1007/s10072-022-06285-4
pmc: PMC9361921
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

5795-5797

Informations de copyright

© 2022. Fondazione Società Italiana di Neurologia.

Références

Zhang X, Wang F, Shen Y et al (2021) Symptoms and health outcomes among survivors of COVID-19 infection 1 year after discharge from hospitals in Wuhan. China JAMA Netw Open 4:e2127403
doi: 10.1001/jamanetworkopen.2021.27403
Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ (2021) 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry 8:416–427
doi: 10.1016/S2215-0366(21)00084-5
Pilotto A, Cristillo V, Cotti Piccinelli S et al (2021) Long-term neurological manifestations of COVID-19: prevalence and predictive factors. Neurol Sci 42:4903–4907
doi: 10.1007/s10072-021-05586-4
Sollini M, Morbelli S, Ciccarelli M et al (2021) Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study. Eur J Nucl Med Mol Imaging 48:3187–3197
doi: 10.1007/s00259-021-05294-3
Hugon J, Msika EF, Queneau M, Farid K, Paquet C (2022) Long COVID: cognitive complaints (brain fog) and dysfunction of the cingulate cortex. J Neurol 269:44–46
doi: 10.1007/s00415-021-10655-x
Hampshire A, Trender W, Chamberlain SR et al (2021) Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine 39:101044
doi: 10.1016/j.eclinm.2021.101044
Cristillo V, Pilotto A, Cotti Piccinelli S et al (2021) Age and subtle cognitive impairment are associated with long-term olfactory dysfunction after COVID-19 infection. J Am Geriatr Soc 69:2778–2780
doi: 10.1111/jgs.17296
Pilotto A, Masciocchi S, Volonghi I et al (2021) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses. Clin Infect Dis 73:e3019–e3026
doi: 10.1093/cid/ciaa1933
Lupien SJ, Maheu F, Tu M, Fiocco A, Schramek TE (2007) The effects of stress and stress hormones on human cognition: implications for the field of brain and cognition. Brain Cogn 65:209–237
doi: 10.1016/j.bandc.2007.02.007
Fiorenzato E, Zabberoni S, Costa A, Cona G (2021) Cognitive and mental health changes and their vulnerability factors related to COVID-19 lockdown in Italy. PLoS ONE 16:e0246204
doi: 10.1371/journal.pone.0246204

Auteurs

Viviana Cristillo (V)

Department of Clinical and Experimental Sciences, Neurology Unit, University of Brescia, P.le Spedali Civili 1, 25123, Brescia, Italy. viviana.cristillo@gmail.com.

Andrea Pilotto (A)

Department of Clinical and Experimental Sciences, Neurology Unit, University of Brescia, P.le Spedali Civili 1, 25123, Brescia, Italy.

Stefano Cotti Piccinelli (SC)

Department of Clinical and Experimental Sciences, Neurology Unit, University of Brescia, P.le Spedali Civili 1, 25123, Brescia, Italy.

Stefano Gipponi (S)

Department of Clinical and Experimental Sciences, Neurology Unit, University of Brescia, P.le Spedali Civili 1, 25123, Brescia, Italy.

Matilde Leonardi (M)

Neurology, Public Health, Disability Unit - Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.

Michela Bezzi (M)

Respiratory Unit, ASST Spedali Civili Di Brescia, Brescia, Italy.

Alessandro Padovani (A)

Department of Clinical and Experimental Sciences, Neurology Unit, University of Brescia, P.le Spedali Civili 1, 25123, Brescia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH